{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:37:29Z","timestamp":1793140649210,"version":"4.5.0"},"publisher-location":"Chichester, UK","reference-count":38,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004694.pub2","type":"reference-entry","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T20:38:24Z","timestamp":1153255104000},"source":"Crossref","is-referenced-by-count":6,"title":["Tiagabine in the treatment of acute affective episodes in bipolar disorder"],"prefix":"10.1002","author":[{"given":"Akshya","family":"Vasudev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Macritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay NK","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD004694.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.4088\/JCP.v60n1107","article-title":"Tiagabine appears not to be efficacious in the treatment of acute mania","volume":"60","author":"Grunze","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004694.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1034\/j.1399-5618.2002.01201.x","article-title":"Tiagabine in treatment refractory bipolar disorder: a clinical case series","volume":"4","author":"Suppes","year":"2002","journal-title":"Bipolar Disorders"},{"issue":"7066","key":"10.1002\/14651858.CD004694.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information.","volume":"313","author":"Altman","year":"1996","journal-title":"British Journal of Medicine"},{"key":"10.1002\/14651858.CD004694.pub2-BIB4|cit4","volume-title":"Diagnostic and statistical manual of mental disorders (DSM-IV)","year":"1994"},{"issue":"4","key":"10.1002\/14651858.CD004694.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1053\/ejpn.2000.0293","article-title":"Provocation of non-convulsive status epilepticus by tiagabine in three adolescent patients","volume":"4","author":"Balslev","year":"2000","journal-title":"European Journal of Paediatric Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004694.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0028-3908(78)90022-9","article-title":"The mania rating scale: scale construction and inter-observer agreement","volume":"17","author":"Bech","year":"1978","journal-title":"Neuropharmacology"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD004694.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1097\/00004714-199604001-00006","article-title":"Role of newer medications for bipolar disorder","volume":"16","author":"Bowden","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD004694.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in Clinical Trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004694.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1528-1157.2001.042suppl.3042.x","article-title":"Tiagabine in clinical practice","volume":"42 Suppl 3","author":"Genton","year":"2001","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD004694.pub2-BIB10|cit10","unstructured":"Higgins JPT Green S Assessment of Study Quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 ] Chichester John Wiley & Sons, Ltd."},{"issue":"4","key":"10.1002\/14651858.CD004694.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10401239809147036","article-title":"Adjunctive tiagabine treatment of psychiatric disorders: three cases","volume":"10","author":"Kauffman","year":"1998","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004694.pub2-BIB12|cit12","first-page":"33","article-title":"Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia","volume":"61 Suppl 4","author":"Keck","year":"2000","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004694.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s001150170032","article-title":"Experience with tiagabine in the clinical practice; new insights as to the efficacy and safety profile","volume":"72","author":"Kellinghaus","year":"2001","journal-title":"Nervenarzt"},{"issue":"4","key":"10.1002\/14651858.CD004694.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/seiz.2001.0594","article-title":"Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature","volume":"11","author":"Kellinghaus","year":"2002","journal-title":"Seizure"},{"issue":"5","key":"10.1002\/14651858.CD004694.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/seiz.1999.0303","article-title":"Tiagabine-induced absence status in idiopathic generalized epilepsy","volume":"8","author":"Knake","year":"1999","journal-title":"Seizure"},{"key":"10.1002\/14651858.CD004694.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.1995.tb06009.x","article-title":"Tiagabine: the safety landscape","volume":"36 Suppl 6","author":"Leppik","year":"1995","journal-title":"Epilepsia"},{"issue":"2-3","key":"10.1002\/14651858.CD004694.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0920-1211(98)00094-1","article-title":"Safety of tiagabine: summary of 53 trials","volume":"33","author":"Leppik","year":"1999","journal-title":"Epilepsy Research"},{"issue":"8","key":"10.1002\/14651858.CD004694.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long term Tiagabine in epilepsy","volume":"38","author":"Mackay","year":"1997","journal-title":"Epilepsia"},{"issue":"11","key":"10.1002\/14651858.CD004694.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1176\/ajp.156.11.1833","article-title":"Adjunctive Tiagabine treatment for major depression","volume":"156","author":"Maltese","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004694.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0387-7604(03)00028-7","article-title":"Non-convulsive status epilepticus associated with tiagabine in a pediatric patient.","volume":"25","author":"Mangano","year":"2003","journal-title":"Brain Development"},{"issue":"9063","key":"10.1002\/14651858.CD004694.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability and the contribution of risk factors: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004694.pub2-BIB22|cit22","article-title":"Preparing and maintaining systematic reviews","volume-title":"Cochrane Collaboration Handbook","author":"Oxman","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD004694.pub2-BIB23|cit23","article-title":"Olanzapine alone or in combination for acute mania (Cochrane Review)","author":"Rendell","year":"2005","journal-title":"The Cochrane Library"},{"issue":"3","key":"10.1002\/14651858.CD004694.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): Psychometric Properties.","volume":"26","author":"Rush","year":"1996","journal-title":"Psychological Medicine."},{"issue":"5","key":"10.1002\/14651858.CD004694.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.1997.00550170069016","article-title":"Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group","volume":"54","author":"Sachdeo","year":"1997","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004694.pub2-BIB26|cit26","first-page":"1","article-title":"The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder","volume":"30","author":"Sachs","year":"2000","journal-title":"Postgraduate Medicine Special report"},{"key":"10.1002\/14651858.CD004694.pub2-BIB27|cit27","volume-title":"The Cochrane Collaboration Handbook","author":"Sackett","year":"1997"},{"issue":"12","key":"10.1002\/14651858.CD004694.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1176\/ajp.156.12.2014-a","article-title":"Tiagabine and the treatment of refractory bipolar disorder","volume":"156","author":"Schaffer","year":"1999","journal-title":"American Journal of Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD004694.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-0327(01)00407-4","article-title":"An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients","volume":"71","author":"Schaffer","year":"2002","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1002\/14651858.CD004694.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1059-1311(96)80111-7","article-title":"Tiagabine and non-convulsive status epilepticus.","volume":"5","author":"Schapel","year":"1996","journal-title":"Seizure"},{"issue":"2","key":"10.1002\/14651858.CD004694.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s004150170244","article-title":"Non-convulsive status epilepticus in two patients receiving tiagabine add-on treatment","volume":"248","author":"Skodda","year":"2001","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD004694.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"issue":"8","key":"10.1002\/14651858.CD004694.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/archpsyc.1992.01820080032005","article-title":"The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description","volume":"49","author":"Spitzer","year":"1992","journal-title":"Archives of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004694.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1528-1157.1995.tb02576.x","article-title":"A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor","volume":"36","author":"Suzdak","year":"1995","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD004694.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jocn.2004.03.027","article-title":"Tiagabine-induced generalised non convulsive status epilepticus in patients with lesional focal epilepsy.","volume":"12","author":"Vinton","year":"2005","journal-title":"Journal of Clinical Neuroscience"},{"key":"10.1002\/14651858.CD004694.pub2-BIB36|cit36","unstructured":"World Health Organisation The World Health Organisation. The ICD-10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines Geneva World Health Organisation"},{"key":"10.1002\/14651858.CD004694.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004694.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/seiz.2001.0560","article-title":"Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure","volume":"11","author":"Zhu","year":"2002","journal-title":"Seizure"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004694.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004694.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:09:24Z","timestamp":1683518964000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004694.pub2"}},"subtitle":[],"editor":[{"given":"Akshya","family":"Vasudev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004694.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004694.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,7,19]]}}}